Donald Staines: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
Notjusttired (talk | contribs) m (Undo revision 110574 by Notjusttired (talk)) |
||
Line 21: | Line 21: | ||
| last3 = Staines | first3 = DR | authorlink3 = Donald Staines | | last3 = Staines | first3 = DR | authorlink3 = Donald Staines | ||
| last4 = Ashton | first4 = KJ | authorlink4 = | | last4 = Ashton | first4 = KJ | authorlink4 = | ||
| last5 = Ramos | first5 = SB | authorlink5 = Sandra Ramos |last6 = Keane | | | last5 = Ramos | first5 = SB | authorlink5 = Sandra Ramos | ||
| last6 = Keane | first6 = J | authorlink6 = | |||
| last7 = Klimas | first7 = NG | authorlink7 = Nancy Klimas | | last7 = Klimas | first7 = NG | authorlink7 = Nancy Klimas | ||
| last8 = Marshall-Gradisnik | first8 = SM | authorlink8 = Sonya Marshall-Gradisnik | | last8 = Marshall-Gradisnik | first8 = SM | authorlink8 = Sonya Marshall-Gradisnik | ||
| title = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal = Journal of Translational Medicine|volume =9|issue = 81|page =| date= 2011| doi= 10.1186/1479-5876-9-81}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)] | | title = Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|journal = Journal of Translational Medicine|volume =9|issue = 81|page =| date= 2011| doi= 10.1186/1479-5876-9-81}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ (Full Text)] | ||
*2012, The Effects of [[Influenza vaccine|Influenza Vaccination]] on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref>{{citation |last1 = Brenu | | *2012, The Effects of [[Influenza vaccine|Influenza Vaccination]] on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref>{{citation | ||
| last1 = Brenu | first1 = Ekua W | authorlink1 = Ekua Brenu | |||
| last2 = van Driel | first2 = Mieke L | authorlink2 = | | last2 = van Driel | first2 = Mieke L | authorlink2 = | ||
| last3 = Staines | first3 = Donald R | authorlink3 = Donald Staines | | last3 = Staines | first3 = Donald R | authorlink3 = Donald Staines | ||
Line 100: | Line 102: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="BrenuEW2014">{{citation |last1 = Brenu | | <ref name="BrenuEW2014">{{citation | ||
| last1 = Brenu | first1 = EW | authorlink1 = Ekua Brenu | |||
| last2 = Huth | first2 = TK | authorlink2 = Teilah Huth | |||
| last3 = Hardcastle | first3 = SL | authorlink3 = Sharni Hardcastle | |||
| last4 = Fuller | first4 = K | authorlink4 = | |||
| last5 = Kaur | first5 = M | authorlink5 = | |||
| last6 = Johnston | first6 = S | authorlink6 = Samantha Johnston | |||
| last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | |||
| last8 = Staines | first8 = D | authorlink8 = Donald Staines | |||
| last9 = Marshall-Gradisnik | first9 = S | authorlink9 = Sonya Marshall-Gradisnik | | last9 = Marshall-Gradisnik | first9 = S | authorlink9 = Sonya Marshall-Gradisnik | ||
| title = The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis | | title = The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis | ||
Line 106: | Line 116: | ||
| pmid = 24343819 | doi = 10.1093/intimm/dxt068 | | pmid = 24343819 | doi = 10.1093/intimm/dxt068 | ||
}}</ref> | }}</ref> | ||
<ref name="Collatz, 2016">{{Citation |last1= Collatz | | <ref name="Collatz, 2016">{{Citation | ||
|last2= Johnston | first2 = Samantha C. | authorlink2 =Samantha Johnston | |last1= Collatz | first1 = Ansel | authorlink1 = | ||
|last2= Johnston | first2 = Samantha C. | authorlink2 =Samantha Johnston | |||
|last3= Staines | first3 = Donald R. | authorlink3 = Donald Staines | |||
|last4= Marshall-Gradisnik| first4 = Sonya M. | authorlink4 = Sonya Marshall-Gradisnik | |last4= Marshall-Gradisnik| first4 = Sonya M. | authorlink4 = Sonya Marshall-Gradisnik | ||
|title = A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | |title = A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | ||
Line 114: | Line 126: | ||
|pmid = 27229907 | |pmid = 27229907 | ||
|doi = 10.1016/j.clinthera.2016.04.038}}</ref> | |doi = 10.1016/j.clinthera.2016.04.038}}</ref> | ||
<ref name="Corbitt, 2018">{{Citation |last1 = Corbitt | | <ref name="Corbitt, 2018">{{Citation | ||
| last1 = Corbitt | first1 = M | authorlink1 = | |||
| last2 = Campagnolo | first2 = N | authorlink2 = | |||
| last3 = Staines | first3 = D | authorlink3 = Donald Staines | |||
| last4 = Marshall-Gradisnik | first4 = S | authorlink4 = Sonya Marshall-Gradisnik | | last4 = Marshall-Gradisnik | first4 = S | authorlink4 = Sonya Marshall-Gradisnik | ||
| title = A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | | title = A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | ||
Line 123: | Line 138: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Eaton, 2018">{{citation |last1 = Eaton | | <ref name="Eaton, 2018">{{citation | ||
| last1 = Eaton | first1 = Natalie | authorlink1 = | |||
| last2 = Cabanas | first2 = Hélène | authorlink2 = Hélène Cabanas | |||
| last3 = Balinas | first3 = Cassandra | authorlink3 = | |||
| last4 = Klein | first4 = Anne | authorlink4 = | |||
| last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | |||
| last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | ||
| title = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation | | title = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation | ||
Line 132: | Line 152: | ||
| last1 = Hardcastle | first1 = Sharni L. | authorlink1 = Sharni Hardcastle | | last1 = Hardcastle | first1 = Sharni L. | authorlink1 = Sharni Hardcastle | ||
| last2 = Brenu | first2 = Ekua W. | authorlink2 = Ekua Brenu | | last2 = Brenu | first2 = Ekua W. | authorlink2 = Ekua Brenu | ||
| last3 = Johnston | first3 = Samantha | authorlink3 = Samantha Johnston | | last3 = Johnston | first3 = Samantha | authorlink3 = Samantha Johnston | ||
| last4 = Nguyen | first4 = Thao | authorlink4 = | |||
| last5 = Huth | first5 = Teilah K. | authorlink5 = Teilah Huth | | last5 = Huth | first5 = Teilah K. | authorlink5 = Teilah Huth | ||
| last6 = Kaur | first6 = Manprit | authorlink6 = | | last6 = Kaur | first6 = Manprit | authorlink6 = | ||
| last7 = Ramos | first7 = Sandra | authorlink7 = Sandra Ramos | |||
| last8 = Salajegheh | first8 = Ali | authorlink8 = | |||
| last9 = Staines | first9 = Donald R. | authorlink9 = Donald Staines | | last9 = Staines | first9 = Donald R. | authorlink9 = Donald Staines | ||
| last10 = Marshall-Gradisnik | first10 = Sonya | authorlink10 = Sonya Marshall-Gradisnik | | last10 = Marshall-Gradisnik | first10 = Sonya | authorlink10 = Sonya Marshall-Gradisnik | ||
Line 144: | Line 167: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hardcastle, 2015">{{Citation |last1 = Hardcastle | | <ref name="Hardcastle, 2015">{{Citation | ||
| last1 = Hardcastle | first1 = SL | authorlink1 = Sharni Hardcastle | |||
| last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | |||
| last3 = Johnston | first3 = S | authorlink3 = Samantha Johnston | |||
| last4 = Nguyen | first4 = T | authorlink4 = | |||
| last5 = Huth | first5 = T | authorlink5 = Teilah Huth | |||
| last6 = Wong | first6 = N | authorlink6 = | |||
| last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | |||
| last8 = Staines | first8 = DR | authorlink8 = Donald Staines | |||
| last9 = Marshall-Gradisnik | first9 = SM | authorlink9 = Sonya Marshall-Gradisnik | |||
| title = Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | | title = Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) | ||
| journal = BMC Immunology | volume = 16 | issue = 35 | page = | | journal = BMC Immunology | volume = 16 | issue = 35 | page = | ||
Line 154: | Line 186: | ||
| last1 = Hardcastle | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle | | last1 = Hardcastle | first1 = Sharni Lee | authorlink1 = Sharni Hardcastle | ||
| last2 = Brenu | first2 = Ekua Weba | authorlink2 = Ekua Brenu | | last2 = Brenu | first2 = Ekua Weba | authorlink2 = Ekua Brenu | ||
| last3 = Johnston | first3 = Samantha | authorlink3 = Samantha Johnston |last4 = Nguyen | | | last3 = Johnston | first3 = Samantha | authorlink3 = Samantha Johnston | ||
| last4 = Nguyen | first4 = Thao | authorlink4 = | |||
| last5 = Huth | first5 = Teilah | authorlink5 = Teilah Huth | |||
| last6 = Ramos | first6 = Sandra | authorlink6 = Sandra Ramos | |||
| last7 = Staines | first7 = Donald | authorlink7 = Donald Staines | |||
| last8 = Marshall-Gradisnik | first8 = Sonya | authorlink8 = Sonya Marshall-Gradisnik | | last8 = Marshall-Gradisnik | first8 = Sonya | authorlink8 = Sonya Marshall-Gradisnik | ||
| title = Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | | title = Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | ||
Line 162: | Line 198: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Hardcastle, 09052015">{{Citation |last1 = Hardcastle | | <ref name="Hardcastle, 09052015">{{Citation | ||
| last1 = Hardcastle | first1 = SL | authorlink1 = Sharni Hardcastle | |||
| last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | |||
| last3 = Johnston | first3 = S | authorlink3 = Samantha Johnston | |||
| last4 = Nguyen | first4 = T | authorlink4 = | |||
| last5 = Huth | first5 = T | authorlink5 = Teilah Huth | |||
| last6 = Wong | first6 = N | authorlink6 = | |||
| last7 = Ramos | first7 = S | authorlink7 = Sandra Ramos | |||
| last8 = Staines | first8 = DR | authorlink8 = Donald Staines | |||
| last9 = Marshall-Gradisnik | first9 = SM | authorlink9 = Sonya Marshall-Gradisnik | |||
| title = Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | | title = Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | ||
| journal = International Journal of Medical Sciences | volume = 12 | issue = 10 | page = 764-772 | | journal = International Journal of Medical Sciences | volume = 12 | issue = 10 | page = 764-772 | ||
Line 170: | Line 215: | ||
</ref> | </ref> | ||
<ref name="Huth, 2014">{{Citation | <ref name="Huth, 2014">{{Citation | ||
| last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth |last2 = Brenu | | | last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth | ||
| last2 = Brenu | first2 = Ekua | authorlink2 = Ekua Brenu | |||
| last3 = Nguyen | first3 = Thao | authorlink3 = | |||
| last4 = Hardcastle | first4 = Sharni L. | authorlink4 = Sharni Hardcastle | | last4 = Hardcastle | first4 = Sharni L. | authorlink4 = Sharni Hardcastle | ||
| last5 = Johnston | first5 = Samantha | authorlink5 = Samantha Johnston |last6 = Ramos | | | last5 = Johnston | first5 = Samantha | authorlink5 = Samantha Johnston | ||
| last6 = Ramos | first6 = Sandra | authorlink6 = Sandra Ramos | |||
| last7 = Staines | first7 = Donald R. | authorlink7 = Donald Staines | | last7 = Staines | first7 = Donald R. | authorlink7 = Donald Staines | ||
| last8 = Marshall-Gradisnik | first8 = Sonya M. | authorlink8 = Sonya Marshall-Gradisnik | | last8 = Marshall-Gradisnik | first8 = Sonya M. | authorlink8 = Sonya Marshall-Gradisnik | ||
Line 183: | Line 231: | ||
</ref> | </ref> | ||
<ref name="Huth, 2016">{{Citation | <ref name="Huth, 2016">{{Citation | ||
| last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth |last2 = Staines | | | last1 = Huth | first1 = Teilah K. | authorlink1 = Teilah Huth | ||
| last2 = Staines | first2 = Donald | authorlink2 = Donald Staines | |||
| last3 = Marshall-Gradisnik | first3 = Sonya | authorlink3 = Sonya Marshall-Gradisnik | | last3 = Marshall-Gradisnik | first3 = Sonya | authorlink3 = Sonya Marshall-Gradisnik | ||
| title = ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | | title = ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | ||
Line 192: | Line 241: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Huth,TK, 2016">{{Citation |last1 = Huth | | <ref name="Huth,TK, 2016">{{Citation | ||
| last1 = Huth | first1 = T.K. | authorlink1 = Teilah Huth | |||
| last2 = Brenu | first2 = E.W. | authorlink2 = Ekua Brenu | |||
| last3 = Staines | first3 = D.R. | authorlink3 = Donald Staines | |||
| last4 = Marshall-Gradisnik | first4 = S.M. | authorlink4 = Sonya Marshall-Gradisnik | | last4 = Marshall-Gradisnik | first4 = S.M. | authorlink4 = Sonya Marshall-Gradisnik | ||
| title = Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | | title = Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients | ||
Line 201: | Line 253: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Marshall-Gradisnik, 2015">{{Citation |last1 = Marshall-Gradisnik | | <ref name="Marshall-Gradisnik, 2015">{{Citation | ||
| last1 = Marshall-Gradisnik | first1 = Sonya M. | authorlink1 = Sonya Marshall-Gradisnik | |||
| last2 = Smith | first2 = Peter | authorlink2 = | |||
| last3 = Brenu | first3 = Ekua W. | authorlink3 = Ekua Brenu | |||
| last4 = Nilius | first4 = Bernd | authorlink4 = | |||
| last5 = Ramos | first5 = Sandra B. | authorlink5 = | |||
| last6 = Staines | first6 = Donald R. | authorlink6 = Donald Staines | |||
| title = Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients | | title = Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients | ||
| journal = Immunology and Immunogenetics Insights | volume = 2015 | issue = 7 | page = 1-6 | | journal = Immunology and Immunogenetics Insights | volume = 2015 | issue = 7 | page = 1-6 | ||
Line 210: | Line 268: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Marshall-Gradisnik,SM 2016">{{Citation |last1 = Marshall-Gradisnik | | <ref name="Marshall-Gradisnik,SM 2016">{{Citation | ||
| last1 = Marshall-Gradisnik | first1 = Sonya M. | authorlink1 =Sonya Marshall-Gradisnik | |||
| last2 = Huth | first2 = Teilah | authorlink2 = Teilah Huth | |||
| last3 = Chacko | first3 = Anu | authorlink3 = Ekua Brenu | |||
| last4 = Johnston | first4 = Samantha | authorlink4 = Samantha Johnston | |||
| last5 = Smith | first5 = Peter | authorlink5 = | |||
| last6 = Staines | first6 = Donald R. | authorlink6 = Donald Staines | |||
| title = Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome | | title = Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome | ||
| journal = The Application of Clinical Genetics | volume = 9 | issue = | page = 39—47 | | journal = The Application of Clinical Genetics | volume = 9 | issue = | page = 39—47 | ||
Line 218: | Line 282: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Nguyen, 2017">{{Citation |last1 = Nguyen | | <ref name="Nguyen, 2017">{{Citation | ||
| last1 = Nguyen | first1 = T. | authorlink1 = | |||
| last2 = Hardcastle | first2 = S. | authorlink2 = Sharni Hardcastle | |||
| last3 = Clarke | first3 = L. | authorlink3 = | |||
| last4 = Smith | first4 = P. | authorlink4 = | |||
| last5 = Staines | first5 = D. | authorlink5 = Donald Staines | |||
| last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | ||
| title = Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels | | title = Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels | ||
Line 226: | Line 295: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Peterson, 2015">{{Citation |last1 = Peterson | | <ref name="Peterson, 2015">{{Citation | ||
| last1 = Peterson | first1 = D | authorlink1 = Daniel Peterson | |||
| last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | |||
| last3 = Gottschalk | first3 = G | authorlink3 = Gunnar Gottschalk | |||
| last4 = Ramos | first4 = Sandra B | authorlink4 = Sandra Ramos | |||
| last5 = Nguyen | first5 = T | authorlink5 = | |||
| last6 = Staines | first6 = D | authorlink6 = Donald Staines | |||
| last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | |||
| title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | ||
| journal = Mediators of Inflammation | volume = 2015 | issue = | page = | | journal = Mediators of Inflammation | volume = 2015 | issue = | page = | ||
Line 233: | Line 309: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Ramos, 2016">{{Citation |last1 = Ramos | | <ref name="Ramos, 2016">{{Citation | ||
| last1 = Ramos | first1 = S | authorlink1 = Sandra Ramos | |||
| last2 = Brenu | first2 = E | authorlink2 = Ekua Brenu | |||
| last3 = Broadley | first3 = S | authorlink3 = | |||
| last4 = Kwiatek | first4 = R | authorlink4 = Richard Kwiatek | |||
| last5 = Ng | first5 = J | authorlink5 = | |||
| last6 = Nguyen | first6 = T | authorlink6 = | |||
| last7 = Freeman | first7 = S | authorlink7 = | |||
| last8 = Staines | first8 = D | authorlink8 = Donald Staines | |||
| last9 = Marshall-Gradisnik | first9 = S | authorlink9 = Sonya Marshall-Gradisnik | |||
| title = Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison | | title = Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison | ||
| journal = Asian Pac J Allergy Immunol | volume = | issue = | page = | | journal = Asian Pac J Allergy Immunol | volume = | issue = | page = | ||
Line 240: | Line 325: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Shan, 2016">{{Citation |last1 = Shan | | <ref name="Shan, 2016">{{Citation | ||
| last1 = Shan | first1 = Zack Y. | authorlink1 =Zack Shan | |||
| last2 = Kwiatek | first2 = Richard | authorlink2 = Richard Kwiatek | |||
| last3 = Burnet | first3 = Richard | authorlink3 =Richard Burnet | |||
| last4 = Del Fante | first4 = Peter | authorlink4 =Peter Del Fante | |||
| last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | |||
| last6 = Marshall‐Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | |||
| last7 = Barnden | first7 = Leighton R. | authorlink7 =Leighton Barnden | |||
| title = Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study | | title = Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study | ||
| journal = Journal of Magnetic Resonance Imaging | volume = 44 | issue = | page = 1301–1311 | | journal = Journal of Magnetic Resonance Imaging | volume = 44 | issue = | page = 1301–1311 | ||
Line 248: | Line 340: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Shan, 2018">{{Citation |last1 = Shan | | <ref name="Shan, 2018">{{Citation | ||
| last1 = Shan | first1 = Zack Y. | authorlink1 = | |||
| last2 = Finegan | first2 = Kevin | authorlink2 = | |||
| last3 = Bhuta | first3 = Sandeep | authorlink3 = | |||
| last4 = Ireland | first4 = Timothy | authorlink4 = | |||
| last5 = Staines | first5 = Donald R. | authorlink5 = Donald Staines | |||
| last6 = Marshall‐Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | |||
| last7 = Barnden | first7 = Leighton R. | authorlink7 = | |||
| title = Brain function characteristics of [[chronic fatigue syndrome]]: A task fMRI study | | title = Brain function characteristics of [[chronic fatigue syndrome]]: A task fMRI study | ||
| journal = NeuroImage: Clinical | volume = 19 | issue = | page = 279-286 | | journal = NeuroImage: Clinical | volume = 19 | issue = | page = 279-286 | ||
Line 256: | Line 355: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Wong, 2015">{{Citation |last1 = Wong | | <ref name="Wong, 2015">{{Citation | ||
| last3 = Brenu | first3 = Ekua Weba | authorlink3 = Ekua Brenu |last4 = Broadley | | | last1 = Wong | first1 = Naomi | authorlink1 = | ||
| last2 = Nguyen | first2 = Thao | authorlink2 = | |||
| last3 = Brenu | first3 = Ekua Weba | authorlink3 = Ekua Brenu | |||
| last4 = Broadley | first4 = Simon | authorlink4 = | |||
| last5 = Staines | first5 = Donald | authorlink5 = Donald Staines | |||
| last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | ||
| title = A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients | | title = A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients |
Revision as of 20:47, May 11, 2022
Professor Donald R. Staines, MBBS, MPH, FAFPHM, FAFOEM, is a Clinical Professor at Menzies Health Institute Queensland and the co-director (alongside Sonya Marshall-Gradisnik) of the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University in Queensland in north-eastern Australia.[1] His research team is working towards discovery of diagnostic tools and treatments for chronic fatigue syndrome.[2]
International Consensus Criteria[edit | edit source]
Staines is one of the authors of the 2011 case definition, International Consensus Criteria.[3]
Diagnostic test[edit | edit source]
In February 2016 the research team led by Donald Staines and Sonya Marshall-Gradisnik announced it had created a diagnostic test for the disease using CD8 T cells.[4] They have been awarded a $4-million grant to be administered during the next five years that will enable them to continue research into developing a diagnostic test for ME/CFS.[5]
Open Letters to The Lancet[edit | edit source]
Three open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Staines, along with 41 colleagues in the ME/CFS field, signed the second letter. In June 2018, Dr. Staines signed the third letter, this time along with approximately 100 colleagues.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
- 19 June 2018, Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog
Notable studies[edit | edit source]
- 2011, Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[6] - (Full Text)
- 2012, The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[7] - (Full Text)
- 2014, Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[8] - (Full Text)
- 2014, The Role of Adaptive and Innate Immune Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[9] - (Full Text)
- 2014, The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings[10] - (Abstract)
- 2014, Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[11] - (Full Text)
- 2015, A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients[12]
- 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients[13] - (Abstract)
- 2015, Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients[14] - (Full Text)
- 2015, Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients[15] - (Full Text)
- 2015, Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[16] - (Full Text)
- 2015, Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[17] - (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[18]
- 2016, Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients[19] - (Full Text)
- 2016, A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[20] -(Abstract)
- 2016, Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study[21] - (Full Text)
- 2016, Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison[22] - (Full Text)
- 2016, ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[23] - (Full Text)
- 2016, Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome[24] - (Full Text)
- 2017, Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review[25] - (Full Text)
- 2017, Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels[26] - (Full Text)
- 2017, Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients[27] - (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[28] - (Full text)
- 2018, Brain function characteristics of chronic fatigue syndrome: A task fMRI study[29] - (Full Text)
- 2018, A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)[30] - (Abstract)
- 2018, A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis[31] - (Full text)
- 2018, Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation[32] - (Full Text)
- 2018, Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation[33] - (Abstract)
- 2018, Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome[34] - (Full Text)
- 2018, Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients[35] - (Full Text)
- 2019, Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study[36] - (Full text)
- 2019, Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients[37] - (Full text)
- 2019, A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)[38] - (Full text)
- 2019, Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients[39] - (Abstract)
- 2019, Intra brainstem connectivity is impaired in chronic fatigue syndrome[40] - (Full text)
- 2019, Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients[41] - (Full text)
- 2020, Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study[42] - (Full text)
- 2020, Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans[43] - (Full text)
- 2021, Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[44] (Full text)
Talks and interviews[edit | edit source]
- 2015, Who Are You? Professor Don Staines, ME/CFS research, Griffith University Gold Coast (31 August 2015)
- 2016, Speaker at the 11th Invest in ME International ME Conference on "Update from NCNED: Receptor identification and intracellular signalling"[45]DVD available
- 2017, Speaker at the 12th Invest in ME International ME Conference; Speech title: Dysregulation of Transient Receptor Potential (TRP) ion channels and calcium in natural killer cells in CFS/ME patients[45] - (Video)
- 2018, Meet the Scientists: Prof Don Staines on ME Australia
- 13 Mar 2019, Immunological & Calcium Signalling Define ME/CFS given at the International Research Symposium, Geelong, Australia, sponsored by Emerge Australia (presentation with Sonya Marshall-Gradisnik)
- 31 May 2019, Speaker at the 14th Invest in ME Conference 2019; Speech title: Transient receptor potential ion channels in the aetiology and pathomechanism of CFS/ME[46] - (Video)
Learn more[edit | edit source]
- Donald Staines Griffith University - Donald Staines
- 2014, Gold Coast’s Griffith University to lead way in the battle against chronic fatigue (Gold Coast Bulletin, July 30 2014)
- 2016, Australian scientists make breakthrough in Chronic Fatigue Syndrome testing
- 2018, Profile in Meet the Scientists: Prof Don Staines
Online presence[edit | edit source]
See also[edit | edit source]
- Sonya Marshall-Gradisnik
- Invest in ME International ME Conference
- National Centre for Neuroimmunology and Emerging Diseases
References[edit | edit source]
- ↑ "National Centre for Neuroimmunology and Emerging Diseases". www.griffith.edu.au. Retrieved November 14, 2019.
- ↑ "Coast team zeroing in on CFS test". www.goldcoastbulletin.com.au. December 1, 2016. Retrieved April 26, 2019.
- ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
- ↑ Australian scientists make breakthrough in Chronic Fatigue Syndrome testing, ABC News (Australia), 29 February 2016
- ↑ "Coast team zeroing in on CFS test". www.goldcoastbulletin.com.au. December 1, 2016. Retrieved April 26, 2019.
- ↑ Brenu, EW; van Driel, ML; Staines, DR; Ashton, KJ; Ramos, SB; Keane, J; Klimas, NG; Marshall-Gradisnik, SM (2011), "Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Translational Medicine, 9 (81), doi:10.1186/1479-5876-9-81
- ↑ Brenu, Ekua W; van Driel, Mieke L; Staines, Donald R; Kreijkamp-Kaspers, Sanne; Hardcastle, Sharni L; Marshall-Gradisnik, Sonya M (2012), "The Effects of Influenza Vaccination on Immune Function in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis" (PDF), International Journal of Clinical Medicine, 3 (6): 544-551, doi:10.4236/ijcm.2012.36098
- ↑ Huth, Teilah K.; Brenu, Ekua; Nguyen, Thao; Hardcastle, Sharni L.; Johnston, Samantha; Ramos, Sandra; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2014), "Characterization of Natural Killer Cell Phenotypes in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Journal of Clinical & Cellular Immunology, 5 (3), doi:10.4172/2155-9899.1000223
- ↑ Brenu, EW; Huth, TK; Hardcastle, SL; Fuller, K; Kaur, M; Johnston, S; Ramos, S; Staines, D; Marshall-Gradisnik, S (2014), "The Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis", International Immunology, 26 (4): 233-42, doi:10.1093/intimm/dxt068, PMID 24343819
- ↑ Johnston, S.C.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (January 2, 2014). "The role of clinical guidelines for chronic fatigue syndrome/myalgic encephalomyelitis in research settings". Fatigue: Biomedicine, Health & Behavior. 2 (1): 28–39. doi:10.1080/21641846.2013.860779. ISSN 2164-1846.
- ↑ Hardcastle, Sharni L.; Brenu, Ekua W.; Johnston, Samantha; Nguyen, Thao; Huth, Teilah K.; Kaur, Manprit; Ramos, Sandra; Salajegheh, Ali; Staines, Donald R.; Marshall-Gradisnik, Sonya (2014), "Analysis of the Relationship between Immune Dysfunction and Symptom Severity in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Journal of Clinical & Cellular Immunology, 5 (190), doi:10.4172/2155-9899.1000190
- ↑ Wong, Naomi; Nguyen, Thao; Brenu, Ekua Weba; Broadley, Simon; Staines, Donald; Marshall-Gradisnik, Sonya (2015), "A Comparison of Cytokine Profiles of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis Patients", International Journal of Clinical Medicine, 6 (10): 769-783, doi:10.4236/ijcm.2015.610103
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2015), "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients", Metabolomics, 11 (6): 1626–1639, doi:10.1007/s11306-015-0816-5
- ↑ Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", International Journal of Medical Sciences, 12 (10): 764-772, doi:10.7150/ijms.12399
- ↑ Marshall-Gradisnik, Sonya M.; Smith, Peter; Brenu, Ekua W.; Nilius, Bernd; Ramos, Sandra B.; Staines, Donald R. (2015), "Examination of Single Nucleotide Polymorphisms (SNPs) in Transient Receptor Potential (TRP) Ion Channels in Chronic Fatigue Syndrome Patients", Immunology and Immunogenetics Insights, 2015 (7): 1-6, doi:10.4137/III.S25147
- ↑ Hardcastle, SL; Brenu, EW; Johnston, S; Nguyen, T; Huth, T; Wong, N; Ramos, S; Staines, DR; Marshall-Gradisnik, SM (2015), "Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", BMC Immunology, 16 (35), doi:10.1186/s12865-015-0101-4
- ↑ Hardcastle, Sharni Lee; Brenu, Ekua Weba; Johnston, Samantha; Nguyen, Thao; Huth, Teilah; Ramos, Sandra; Staines, Donald; Marshall-Gradisnik, Sonya (2015), "Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 13 (299), doi:10.1186/s12967-015-0653-3
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, Sandra B; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Huth, T.K.; Brenu, E.W.; Staines, D.R.; Marshall-Gradisnik, S.M. (2016), "Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients", Gene Regulation and Systems Biology, 10: 43–49, doi:10.4137/GRSB.S39861
- ↑ Collatz, Ansel; Johnston, Samantha C.; Staines, Donald R.; Marshall-Gradisnik, Sonya M. (2016), "A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Clinical Therapeutics, 38 (6): 1263-1271.e9, doi:10.1016/j.clinthera.2016.04.038, PMID 27229907
- ↑ Shan, Zack Y.; Kwiatek, Richard; Burnet, Richard; Del Fante, Peter; Staines, Donald R.; Marshall‐Gradisnik, Sonya; Barnden, Leighton R. (2016), "Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study", Journal of Magnetic Resonance Imaging, 44: 1301–1311, doi:10.1002/jmri.25283
- ↑ Ramos, S; Brenu, E; Broadley, S; Kwiatek, R; Ng, J; Nguyen, T; Freeman, S; Staines, D; Marshall-Gradisnik, S (March 20, 2016), "Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison", Asian Pac J Allergy Immunol, doi:10.12932/AP0733
- ↑ Huth, Teilah K.; Staines, Donald; Marshall-Gradisnik, Sonya (2016), "ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients", Journal of Translational Medicine, 14 (97), doi:10.1186/s12967-016-0859-z
- ↑ Marshall-Gradisnik, Sonya M.; Huth, Teilah; Chacko, Anu; Johnston, Samantha; Smith, Peter; Staines, Donald R. (2016), "Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome", The Application of Clinical Genetics, 9: 39—47, doi:10.2147/TACG.S99405
- ↑ Campagnolo, N.; Johnston, S.; Collatz, A.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2017). "Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review". Journal of Human Nutrition and Dietetics. 30 (3): 247–259. doi:10.1111/jhn.12435. ISSN 0952-3871. PMID 28111818.
- ↑ Nguyen, T.; Hardcastle, S.; Clarke, L.; Smith, P.; Staines, D.; Marshall-Gradisnik, S. (2017), "Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels", Clinical and Experimental Immunology, 187 (2): 284–293, doi:10.1111/cei.12882
- ↑ Nguyen, T.; Johnston, S.; Chacko, A.; Gibson, D.; Cepon, J.; Smith, D.; Staines, D.; Marshall-Gradisnik, S. (2017), "Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients", Asian Pac J Allergy Immunol, 35 (2): 75-81, doi:10.12932/AP0771
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ Shan, Zack Y.; Finegan, Kevin; Bhuta, Sandeep; Ireland, Timothy; Staines, Donald R.; Marshall‐Gradisnik, Sonya; Barnden, Leighton R. (2018), "Brain function characteristics of chronic fatigue syndrome: A task fMRI study", NeuroImage: Clinical, 19: 279-286, doi:10.1016/j.nicl.2018.04.025
- ↑ Corbitt, M; Campagnolo, N; Staines, D; Marshall-Gradisnik, S (2018), "A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)", Probiotics Antimicrob Proteins, doi:10.1007/s12602-018-9397-8
- ↑ Du Preez, S.; Corbitt, M.; Cabanas, H.; Eaton, N.; Staines, D.; Marshall-Gradisnik, S. (December 20, 2018). "A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis". Systematic Reviews. 7 (1): 241. doi:10.1186/s13643-018-0909-0. ISSN 2046-4053. PMID 30572962.
- ↑ Eaton, Natalie; Cabanas, Hélène; Balinas, Cassandra; Klein, Anne; Staines, Donald R.; Marshall-Gradisnik, Sonya (2018), "Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation", BMC Pharmacology & Toxicology, 19 (12), doi:10.1186/s40360-018-0203-8, PMID 29587879
- ↑ Nguyen, T.; Staines, D.; Johnston, S.; Marshall-Gradisnik, S. (July 2018), "Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation", Asian Pac J Allergy Immunol, doi:10.12932/AP-011117-0188
- ↑ Barnden, Leighton R.; Shan, Zack Y.; Staines, Donald R.; Marshall-Gradisnik, Sonya; Finegan, Kevin; Ireland, Timothy; Bhuta, Sandeep (2018). "Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome". NeuroImage: Clinical. 20: 102–109. doi:10.1016/j.nicl.2018.07.011.
- ↑ Cabanas, Hélène; Muraki, Katsuhiko; Eaton, Natalie; Balinas, Cassandra; Staines, Donald; Marshall-Gradisnik, Sonya (August 14, 2018). "Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients". Molecular Medicine. 24 (1). doi:10.1186/s10020-018-0046-1. ISSN 1076-1551.
- ↑ Słomko, Joanna; Newton, Julia L; Kujawski, Sławomir; Tafil-Klawe, Małgorzata; Klawe, Jacek; Staines, Donald; Marshall-Gradisnik, Sonya; Zalewski, Pawel (March 2019). "Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study". BMJ Open. 9 (3): e023955. doi:10.1136/bmjopen-2018-023955. ISSN 2044-6055. PMID 30850404.
- ↑ Cabanas, H.; Muraki, K.; Balinas, C.; Eaton-Fitch, N.; Staines, D.; Marshall-Gradisnik, S. (December 2019). "Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients". Molecular Medicine. 25 (1). doi:10.1186/s10020-019-0083-4. ISSN 1076-1551.
- ↑ Corbitt, Matthew; Eaton-Fitch, Natalie; Staines, Donald; Cabanas, Hélène; Marshall-Gradisnik, Sonya (December 2019). "A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)". BMC Neurology. 19 (1). doi:10.1186/s12883-019-1433-0. ISSN 1471-2377. PMID 31445522.
- ↑ Cabanas, Helene; Muraki, Katsuhiko; Staines, Donald; Marshall-Gradisnik, Sonya (October 14, 2019). "Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients". Frontiers in Immunology. doi:10.3389/fimmu.2019.02545.
- ↑ Barnden, Leighton R; Shan, Zack Y; Staines, Donald R; Marshall-Gradisnik, Sonya; Finegan, Kevin; Ireland, Timothy; Bhuta, Sandeep (2019). "Intra brainstem connectivity is impaired in chronic fatigue syndrome". NeuroImage: Clinical. 24: 102045. doi:10.1016/j.nicl.2019.102045.
- ↑ Balinas, Cassandra; Cabanas, Hélène; Staines, Donald; Marshall-Gradisnik, Sonya (December 3, 2019). "Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients". Journal of Translational Medicine. 17 (1): 401. doi:10.1186/s12967-019-02155-4. ISSN 1479-5876. PMC 6891975. PMID 31796045.
- ↑ Eaton-Fitch, N.; Johnston, S. C.; Zalewski, P.; Staines, D.; Marshall-Gradisnik, S. (January 22, 2020). "Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study". Quality of Life Research. doi:10.1007/s11136-019-02411-6. ISSN 0962-9343.
- ↑ Thapaliya, Kiran; Marshall-Gradisnik, Sonya; Staines, Don; Barnden, Leighton (2020). "Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans". NeuroImage: Clinical. 28: 102366. doi:10.1016/j.nicl.2020.102366. PMC 7417892. PMID 32777701.
- ↑ Maksoud, Rebekah; Eaton-Fitch, Natalie; Matula, Michael; Cabanas, Hélène; Staines, Donald; Marshall-Gradisnik, Sonya (May 2021). "Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (5): 568. doi:10.3390/healthcare9050568.
- ↑ 45.0 45.1 "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved April 26, 2019.
- ↑ "Invest in ME Research - IIMEC14 14th Invest in ME Reseaerch International ME Conference 2019". Invest in ME Research. Retrieved February 26, 2020.